Dupilumab (Dupixent(®)) tends to be an effective therapy for uncontrolled severe chronic rhinosinusitis with nasal polyps: real data of a single-centered, retrospective single-arm longitudinal study from a university hospital in Germany

INTRODUCTION: Chronic rhinosinusitis with nasal polyps (CRSwNP) is an inflammatory disease, which is usually type 2-mediated in the western hemisphere, associated with severe therapeutic and socioeconomic challenges. The first targeted systemic treatment option for severe uncontrolled CRSwNP is a hu...

Descripción completa

Detalles Bibliográficos
Autores principales: Jansen, Florian, Becker, Benjamin, Eden, Jördis K., Breda, Philippe C., Hot, Amra, Oqueka, Tim, Betz, Christian S., Hoffmann, Anna S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Rhinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988751/
https://www.ncbi.nlm.nih.gov/pubmed/36242612
http://dx.doi.org/10.1007/s00405-022-07679-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988751/
https://www.ncbi.nlm.nih.gov/pubmed/36242612
http://dx.doi.org/10.1007/s00405-022-07679-y

Ejemplares similares